A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION

DSpace/Manakin Repository

A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Austin, Susan A. en_US
dc.date.accessioned 2012-07-06T22:04:29Z
dc.date.issued 1995 en_US
dc.identifier.citation A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION (1995 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965616
dc.description.abstract Over the past twenty years, physicians have carried out bone marrow transplants with increasing success. As the procedure gains in acceptance and availability over the coming years, our nation will be faced with important policy choices regarding the regulation of bone marrow transplantation. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject national marrow donor program en
dc.subject FDA en
dc.subject regulation en
dc.title A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T22:04:29Z

Files in this item

Files Size Format View
saustin.pdf 137.9Kb PDF View/Open
saustin.rtf 48.77Kb RTF file View/Open
saustin.html 38.44Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters